Showing 1,541 - 1,560 results of 123,309 for search '(( a ((we decrease) OR (mean decrease)) ) OR ( i ((largest decrease) OR (larger decrease)) ))', query time: 1.59s Refine Results
  1. 1541

    Table_1_Decreased Steroid Hormone Receptor NR4A2 Expression in Kawasaki Disease Before IVIG Treatment.docx by Ying-Hsien Huang (446595)

    Published 2019
    “…After PCR validation, our data only revealed decreased NR4A2 mRNA expression in the KD patients compared to those of the controls, which increased after they received IVIG treatment. …”
  2. 1542

    Table_2_Decreased Steroid Hormone Receptor NR4A2 Expression in Kawasaki Disease Before IVIG Treatment.docx by Ying-Hsien Huang (446595)

    Published 2019
    “…After PCR validation, our data only revealed decreased NR4A2 mRNA expression in the KD patients compared to those of the controls, which increased after they received IVIG treatment. …”
  3. 1543

    Table_3_Decreased Steroid Hormone Receptor NR4A2 Expression in Kawasaki Disease Before IVIG Treatment.doc by Ying-Hsien Huang (446595)

    Published 2019
    “…After PCR validation, our data only revealed decreased NR4A2 mRNA expression in the KD patients compared to those of the controls, which increased after they received IVIG treatment. …”
  4. 1544
  5. 1545
  6. 1546

    Pups' weight but not litter size is decreased by prenatal exposure to arsenic. by Andrea A. Cronican (284716)

    Published 2013
    “…<p><b>A</b>. The mean weight of the pups is decreased approximately by 10% in arsenic treated mothers. …”
  7. 1547
  8. 1548
  9. 1549
  10. 1550
  11. 1551
  12. 1552

    Percent changes (Δ-values are differences between means) in protein levels and proteolytic activity of Separase after IM treatment when compared to corresponding untreated cells. by Wiltrud Haaß (312818)

    Published 2015
    “…<p><sup>1</sup> Δ-values were calculated from significant data sets diagrammed in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0129648#pone.0129648.g001" target="_blank">Fig 1</a>. …”
  13. 1553

    Table_1_Can We Boost Treatment Adherence to an Online Transdiagnostic Intervention by Adding Self-Enhancement Strategies? Results From a Randomized Controlled Non-inferiority Trial... by Andreea Bogdana Isbăşoiu (11784218)

    Published 2021
    “…By this mean we intend to complement the symptom-focused assignments, which may be more suitable in a therapist assisted context, with ones designed for self-enhancement, which may be easier approached as self-initiated. …”
  14. 1554

    (R)-albuterol decreases cytokine protein levels in activated T cells by Marcela A Ferrada (41716)

    Published 2011
    “…</p><p></p> (R)-albuterol, (S)-albuterol or racemic albuterol (R + S) at a dose (10M) were added to T (EL-4) cells pre-activated with mitogens Concanavalin A (Con A, 5 μg/ml) and phorbol myristate acetate (PMA, 100 ng/ml) (CP). …”
  15. 1555

    MMP-2 production is decreased following ALK5 inhibition. by Rebecca A. Scott (488956)

    Published 2020
    “…<p>MMP-2 production was decreased in co-cultures treated with 1 μM A83-01 compared to DMSO-treated controls, as detected via ELISA. …”
  16. 1556
  17. 1557

    (R)-albuterol decreases cytokine levels in activated murine splenocytes by Marcela A Ferrada (41716)

    Published 2011
    “…</p><p></p> (R)-albuterol (R), (S)-albuterol (S) or racemic albuterol (R + S) at a dose (10M) were added to murine splenocytes pre-activated with mitogens Concanavalin A (Con A, 5 μg/ml) and phorbol myristate acetate (PMA, 100 ng/ml) (CP), (Fig 3 A, B). …”
  18. 1558
  19. 1559
  20. 1560